Treatment of severe hypocalcaemia due to osteoblastic metastases in a patient with post-thyroidectomy hypoparathyroidism with 153 Sm-EDTMP

BMJ Case Reports
Eva KassiHelen Gogas

Abstract

Symptomatic hypocalcaemia is an uncommon finding in patients with malignant tumours. We describe a patient with advanced metastatic breast cancer who developed severe hypocalcaemia caused by the combination of osteoblastic metastases and a permanent postoperative hypoparathyroidism. The patient failed to be treated with the conventional replacement therapy and was submitted effectively to radionucleotide therapy with 153Sm.

References

Dec 1, 1989·Journal of Internal Medicine·J A RianchoJ González-Macías
Jan 1, 1986·Acta Medica Scandinavica·C P Blomqvist
Mar 6, 1982·British Medical Journal·D B FreedmanA V Hoffbrand
May 4, 2007·The New England Journal of Medicine·Dennis M BlackUNKNOWN HORIZON Pivotal Fracture Trial
Jun 29, 2012·Breast Care·Manfred Fischer, Willm U Kampen
Oct 29, 2013·Journal of Palliative Medicine·Hilda Alfaro RiverosJosep Planas Domingo
Nov 1, 2012·Journal of Bone Metabolism·Won-Seok DoDuk-Hyun Lee
Jun 26, 2014·Swiss Medical Weekly·Veronika KreutleKatrin Borm

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.